Atlas Trials

A Study of MEDI-575 in Subjects With Recurrent Glioblastoma Multiforme

Clinical trial NCT01268566 · COMPLETED

Trial details

NCT number
NCT01268566
Sponsor
MedImmune LLC
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Glioblastoma Multiforme
Start date
2011-01-01
Primary completion
2012-11-01
Enrollment
62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.